Maureen Dubreuil MD, MSc.

Associate Professor, Rheumatology

650 Albany St | (617) 638-5180
maureen.dubreuil@bmc.org
mdubreui@bu.edu

Sections

Rheumatology

Centers

Arthritis & Autoimmune Diseases Research Center

Biography

Dr. Dubreuil is a rheumatologist in Boston, specializing in spondyloarthritis. She works within the Rheumatology section at Chobanian and Avedisian School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. Dr. Dubreuil's research has been funded by numerous competitive grants from funders including the NIH, private foundations and industry. Some highlights of Dr. Dubreuil's work includes:
1. Discovery of two key protective effects of TNF inhibitors against fractures and cardiovascular events in spondyloarthritis
2. Finding that a common nonsteroidal anti-inflammatory drug is associated with 3 times the risk of heart attack among people with spondyloarthritis
3. Development of the first North American guidelines for referral of adults at increased risk of having spondyloarthritis to a rheumatologist

In addition to her research, Dr. Dubreuil is a member of the leading international organizations for spondyloarthritis research. She serves on the Executive Committee of the Board of Directors for the Spondyloarthritis Research and Treatment Network, and on the Medical Advisory Board for the Spondylitis Association of America. She is a site investigator for the international CLASSIC study in spondyloarthritis. Dr. Dubreuil is the Director of Research Training for the Rheumatology Fellowship program at Boston Medical Center.

Dr. Dubreuil cares for people with rheumatic conditions at Boston Medical Center and the VA Boston Healthcare System. Dr. Dubreuil's patients say the following about her:
"Dr. Dubreuil is a very caring and knowledgeable doctor and it's always a pleasure to be seen by her."
"I am very satisfied with the care I have received. My provider and the support staff is very professional, caring and concerned. I would recommend to anyone."
"Dr. Dubreuil is a gem and I feel so lucky to have her!"
A survey of 40 patients who received care by Dr. Dubreuil in 2024-2025 found that 100% would recommend her!

Websites

BU Profile

Dr. Dubreuil's publications on PubMed

Dr. Dubreuil's profile on LinkedIn

Rheumatology Faculty at BU Medical Center

BU Rheumatology

BU Musculoskeletal Clinical Research Collaboratory

American College of Rheumatology Abstracts by Dr. Dubreuil

ACR On Air Podcast Episode: Treating Spondyloarthritis

BU Rheumatology Fellowship Program Video

An interview on WebMD about Ankylosing Spondylitis

SPARTAN (Spondyloarthritis Research and Treatment Network)

Spondylitis Association of America

Dr. Dubreuil's ABIM Certification in Rheumatology

Education

Medicine-Internal, MD, University of Connecticut School of Medicine

MSc, Boston University School of Public Health

Biology, BS, Rochester Institute of Technology

Publications

Published on 9/22/2025

Degirmenci HB, Peloquin CE, Westerland M, Lodi S, Machado PM, Jafarzadeh SR, Neogi T, Gensler LS, Dubreuil M, Liew JW. Trends in Opioid Prescriptions in Individuals With Axial Spondyloarthritis in the United States and United Kingdom in the Last Two Decades: Analysis of Electronic Health Records and Insurance Claims Data. Arthritis Care Res (Hoboken). 2025 Sep 22. PMID: 40977482.

PubMed

Published on 9/11/2025

Achkar A, Peloquin C, Liew JW, Dubreuil M. Targeted and biologic therapies and risk of total knee or hip replacement in axial spondyloarthritis and psoriatic arthritis. Clin Rheumatol. 2025 Oct; 44(10):4005-4013. PMID: 40936006.

PubMed

Published on 9/1/2025

Dubreuil M, Walsh JA, Deodhar A, Gensler LS, Curtis JR, Welby S, Pilipczuk O, Beaty S, Mørup MF, Taieb V, Anjohrin S. Real-World Use of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis in the United States: Persistence, Variables Associated With Persistence, and Dosing Variations. Pharmacoepidemiol Drug Saf. 2025 Sep; 34(9):e70197. PMID: 40854555.

PubMed

Published on 8/29/2025

Dubreuil M, Magrey M, Haeffs K, Ivanov E, Gandrup Horan J. Patient Diagnostic Journey and Time to Diagnosis in Axial Spondyloarthritis: A Retrospective Cohort Study Using US Claims Data. Rheumatol Ther. 2025 Oct; 12(5):991-1006. PMID: 40879862.

PubMed

Published on 6/1/2025

Sendaydiego X, Gold LS, Dubreuil M, Andrews JS, Reid P, Liew DFL, Goulabchand R, Hughes GC, Sparks JA, Jarvik JG, Singh S, Liew JW, Singh N. Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis. Rheumatology (Oxford). 2025 Jun 01; 64(6):3434-3443. PMID: 39936579.

PubMed

Published on 4/28/2025

Neogi T, Dubreuil M, Peloquin C, Marinko L, Camarinos J, Felson DT, Kumar D. Reply. Arthritis Rheumatol. 2025 Apr 28. PMID: 40289862.

PubMed

Published on 4/2/2025

Neogi T, Dubreuil M, Peloquin C, Marinko L, Camarinos J, Felson DT, Kumar D. Association of Physical Therapy Care With Use of Intra-Articular Injections in People With Knee Osteoarthritis: A Real-World Cohort Study. Arthritis Rheumatol. 2025 Aug; 77(8):1006-1014. PMID: 40091450.

PubMed

Published on 4/1/2025

Ferrandiz-Espadin R, Rabasa G, Gasman S, McGinley B, Stovall R, Jafarzadeh SR, Liew JW, Dubreuil M. Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis. J Rheumatol. 2025 Apr 01; 52(4):344-351. PMID: 39486857.

PubMed

Published on 3/24/2025

Ualiyeva S, Basu A, Roguski M, Degirmenci HB, Dubreuil M, Erdil RM, Garibyan L, Arkun K. Molecular detection of Tropheryma whipplei DNA: a crucial tool for diagnosing Whipple's disease in the brain. Illustrative case. J Neurosurg Case Lessons. 2025 Mar 24; 9(12). PMID: 40127479.

PubMed

Published on 3/15/2025

Choufani M, Ghusn W, Dubreuil M, Ermann J. Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region. J Rheumatol. 2025 Mar 15. PMID: 40089303.

PubMed

View full list of 81 publications.